The estimated Net Worth of Richard E Uihlein is at least $28.2 Milhão dollars as of 26 September 2023. Mr. Uihlein owns over 2,236,204 units of Galectin Therapeutics Inc stock worth over $28,045,256 and over the last 7 years he sold GALT stock worth over $0. In addition, he makes $188,255 as Independent Chairman of the Board at Galectin Therapeutics Inc.
Richard has made over 7 trades of the Galectin Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 2,236,204 units of GALT stock worth $10,040,556 on 26 September 2023.
The largest trade he's ever made was buying 4,680,606 units of Galectin Therapeutics Inc stock on 29 May 2019 worth over $20,032,994. On average, Richard trades about 416,795 units every 100 days since 2017. As of 26 September 2023 he still owns at least 10,235,495 units of Galectin Therapeutics Inc stock.
You can see the complete history of Mr. Uihlein stock trades at the bottom of the page.
Richard E. Uihlein serves as Independent Chairman of the Board of the Company. He has been a director since 2017 and Chairman since May 2018, co-founded Uline, Inc. (a leading distributor of shipping, packaging and industrial supplies) in 1980, and has served as its Chief Executive Officer and Chairman since its founding. Prior to founding Uline Inc., Mr. Uihlein was employed at General Bindings Corp., Northbrook, IL from 1967 to 1980. Mr. Uihlein graduated from Stanford University, Palo Alto, CA. with a BA degree in history in 1967.
As the Independent Chairman of the Board of Galectin Therapeutics Inc, the total compensation of Richard Uihlein at Galectin Therapeutics Inc is $188,255. There are 7 executives at Galectin Therapeutics Inc getting paid more, with Harold Shlevin having the highest compensation of $1,306,510.
Richard Uihlein is 75, he's been the Independent Chairman of the Board of Galectin Therapeutics Inc since 2018. There are 2 older and 17 younger executives at Galectin Therapeutics Inc. The oldest executive at Galectin Therapeutics Inc is Gilbert Omenn, 79, who is the Independent Director.
Richard's mailing address filed with the SEC is 12575 Uline Dr, Pleasant Prairie, WI 53158, USA.
Over the last 14 years, insiders at Galectin Therapeutics Inc have traded over $21,823,082 worth of Galectin Therapeutics Inc stock and bought 5,077,107 units worth $21,362,250 . The most active insiders traders include Richard E Uihlein, James C Czirr, eFund, L.P.10 X Capital Mana.... On average, Galectin Therapeutics Inc executives and independent directors trade stock every 27 days with the average trade being worth of $226,012. The most recent stock trade was executed by Richard A. Jr. Zordani on 22 August 2024, trading 3,500 units of GALT stock currently worth $8,050.
galectin therapeutics (nasdaq: galt) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. drug candidates based on the company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. we use naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. we focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. our strategy is to establish clinical development approaches that add value to the company in the shortest time possible, and to seek partners as the program advances and requires much
Galectin Therapeutics Inc executives and other stock owners filed with the SEC include: